The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

A systematic analysis, published in The Lancet Microbe, presented the first catalogue, endorsed by the World Health Organization (WHO), of molecular targets for Mycobacterium tuberculosis complex drug susceptibility testing, intended to provide a global standard for resistance interpretation. The existence of this catalogue is expected to encourage the implementation of molecular diagnostics by national TB programs.